The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects RAHWAY, NJ, Oct. 20, 2025 – Merck (NYSE: MRK), known as MSD...

New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines including weight management, metabolic and cancer technologies Facility marks...

BUILT Biotechnologies, an emerging leader in DNA Manufacturing-as-a-Service, today announced its selection as an anchor company at the Commonwealth BioAccelerator, an initiative led by CvilleBioHub to strengthen Virginia’s biotechnology ecosystem....

FOR IMMEDIATE RELEASE September 19, 2025 Virginia Biotech Shines:  CvilleBioHub Celebrates Breakthrough Week with BioDiscovery Summit and BioSpark Winners Charlottesville, VA — This week marked a milestone moment for Virginia’s...

INDIANAPOLIS, Sept. 16, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County. The new site will be the...

Innovation born in Charlottesville continues to advance patient care. Rivanna Medical has introduced the Accuro 3S, the first FDA-cleared system to provide real-time ultrasound guidance for spinal and epidural anesthesia....

  FOR IMMEDIATE RELEASE CvilleBioHub Announces 2025 BioSpark Pitch Competition Participants Charlottesville, VA September 9, 2025 –  CvilleBioHub, in partnership with Cooley, today announced the eight early-stage life sciences startups...

Charlottesville, VA — August 11, 2025  CvilleBioHub will expand the Commonwealth BioAccelerator and state-of-the-art facilities at the North Fork Discovery Park. The expansion is powered by a transformational $15 million...

Adovate is pleased to announce that it has successfully closed and oversubscribed its $6 million Convertible Note financing round. The strong interest in this round reflects continued support for our...

WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical...

The bright morning wind skips off Chesapeake Bay and whistles through the historic ironwork and brick frontages of Norfolk’s seafront. Hunter Walsh bowls into his office in Hampton Roads’ cluster...

TROY, Va. and SHAKOPEE, Minn., May 20, 2025 /PRNewswire/ — As consumer demand for clean-label, organic, and non-GMO products continues to surge, the pressure is mounting on ingredient suppliers to meet stringent certification standards...